SSA
CRXT

Schonfeld Strategic Advisors’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CRXT Stock Details CRXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-20,800
Closed -$51K – 2999
2021
Q4 		$51K Buy
+20,800
New +$51K ﹤0.01% 1876
2021
Q3 		– Sell
-30,000
Closed -$302K – 2525
2021
Q2 		$302K Buy
30,000
+19,026
+173% +$192K ﹤0.01% 1426
2021
Q1 		$111K Buy
+10,974
New +$111K ﹤0.01% 1580